ESC 365 - Doctor Clotilde Roy

Speaker illustration

Doctor Clotilde Roy

Jolimont Lobbes Hospital, La Louviere (Belgium)

Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction

Event: ESC Congress 2018

Topic: Biomarkers

Session: Exploring biomarkers in heart failure

Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction

Event: ESC Congress 2018

Topic: Biomarkers

Session: Exploring biomarkers in heart failure

Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction

Event: Heart Failure 2018

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography

Prognostic relevance of right ventricle global longitudinal strain in heart failure with preserved ejection fraction.

Event: Heart Failure 2018

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Moderated Poster session 1 - Diagnosis and biomarkers

Age and gender interaction with t1, t2, t2* and extracellular volume reference values in healthy volunteers at 3 tesla cardiac magnetic resonance.

Event: EuroCMR 2017

Topic: Cardiac Magnetic Resonance

Session: Oral abstract session 4

Prognostic significance of diffuse myocardial fibrosis evaluated by cMR in patients with heart failure with preserved ejection fraction.

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources